Editor's Choice
Editorial | Top-down and bottom-up approaches to low-value care
15 Feb, 2023 | 16:08h | UTCTop-down and bottom-up approaches to low-value care = BMJ Quality & Safety
Original Study: Evaluation of the NHS England evidence-based interventions programme: a difference-in-difference analysis – BMJ Quality & Safety
Commentary on Twitter
In this editorial, @andreapatey & @christinesoong discuss combining top-down ⬇️ and bottom-up ⬆️ approaches to effectively de-implement and reduce low-value care. https://t.co/mYJHkkJpSk
— BMJ Quality & Safety (@BMJ_Qual_Saf) February 10, 2023
Worsening heart failure: nomenclature, epidemiology, and future directions
15 Feb, 2023 | 16:06h | UTC
Cohort Study | Incidence of acute cardiac events during COVID-19-associated hospitalizations
15 Feb, 2023 | 16:05h | UTC
Consensus Paper | ED management of patients with alcohol intoxication, alcohol withdrawal, and alcohol use disorder
14 Feb, 2023 | 11:05h | UTC
Diagnostic Study | Level of attention to motherese speech as an early marker of autism spectrum disorder
14 Feb, 2023 | 11:04h | UTCSummary: A study was conducted to determine if levels of attention to motherese speech can be used as a diagnostic marker for autism spectrum disorder (ASD) and if they are associated with social and language abilities. The study involved 653 toddlers aged 12 to 48 months and used gaze-contingent eye tracking to measure attention to motherese speech. The results showed that toddlers without ASD had high levels of fixation on motherese speech, while those with ASD had significantly reduced levels. If a toddler fixated on motherese speech at or below 30%, the probability of them being accurately diagnosed with ASD was 94%, and it was also associated with reduced social and language abilities. The findings suggest that attention to motherese speech may be a diagnostic and prognostic marker of ASD.
(By ChatGPT, reviewed and edited)
Commentaries:
Toddlers’ Attention to ‘Motherese’ Could Give Clues to Autism – HealthDay
Developments under assisted dying legislation: the experience in Belgium and other countries
14 Feb, 2023 | 11:02h | UTCSummary: The legalization of assisted dying (including euthanasia and physician-assisted suicide) remains a controversial issue as more countries consider such laws. A selective literature review was conducted to examine the developments globally, and the experience in Belgium was found to be instructive. Since legalization, the practice of assisted dying has increased gradually, accompanied by a growing acceptance among the public and physicians. Although fears have been largely alleviated, ongoing monitoring and research are necessary to address important concerns. Research in Belgium has not found evidence of harmful effects, but the implementation of assisted dying laws should always consider integration into the healthcare system, physician training, conscientious objection, availability of palliative care, public education, and monitoring systems. To ensure the quality of end-of-life care, it is advisable to set up monitoring and evaluation systems and carry out impartial studies. It is important to have high levels of openness and involvement with healthcare providers and the general public.
(By ChatGPT, reviewed and edited)
Performance of ChatGPT on USMLE: potential for AI-assisted medical education using large language models
14 Feb, 2023 | 11:00h | UTCSummary: The researchers evaluated the performance of ChatGPT, a large language-based AI, on the United States Medical Licensing Exam (USMLE). The USMLE is a set of three standardized tests required for medical licensure in the US. The results showed that ChatGPT performed at or near the passing threshold (60%) on all three exams without specialized training or reinforcement. The AI also demonstrated a high level of concordance and insight in its explanations, suggesting that it may have potential to assist with medical education and potentially, clinical decision-making in the future. This marks a notable milestone in AI maturation and increased confidence in its trust and explainability.
(By ChatGPT, reviewed and edited)
News Release: ChatGPT can (almost) pass the US Medical Licensing Exam – PLOS
Commentaries:
Commentary from one of the authors on Twitter (thread – click for more)
our work showing that ChatGPT passed the US Medical Licensing Exam (USMLE) is published @PLOSDigiHealth!
there's tons of chatter about LLMs in healthcare.
AI is not going to replace doctors anytime soon, but here are the key takeaways from this work:
👉 https://t.co/OQs2Tlfwjx pic.twitter.com/v3UWjScLth
— Morgan Cheatham (@morgancheatham) February 13, 2023
Perspective | ChatGPT-assisted diagnosis: is the future suddenly here?
14 Feb, 2023 | 10:59h | UTCSummary: The article discusses the potential of ChatGPT, a new AI chatbot, to revolutionize medical diagnosis. It compares ChatGPT’s performance with that of symptom checkers and physicians, finding that it performs better than symptom checkers and is approaching the accuracy of physicians. The article highlights the limitations of the study, including the small sample size and sensitivity of results to the way information is presented. It also acknowledges potential challenges with the use of AI in medical diagnosis, including the need for more rigorous testing, the issue of feeding patient information into an algorithm, and the possibility of AI algorithms being biased. Despite these challenges, the article suggests that the future of computer-assisted diagnosis is here and the healthcare system will need to address these challenges.
(By ChatGPT, reviewed and edited)
Source: ChatGPT-assisted diagnosis: Is the future suddenly here? – STAT
Opinion | The “evidence pyramid” should be dismantled, brick by ill-conceived brick
14 Feb, 2023 | 10:57h | UTCSummary: The text criticizes the use of the so-called “evidence pyramid” in medicine, which suggests that systematic reviews and meta-analyses (SRMAs) are the highest level of evidence in medicine. The author argues that SRMAs are not evidence themselves, but a lens through which actual evidence from randomized controlled trials (RCTs) and observational studies is viewed. They depend on the quality of the review process and the evidence appraised, which are often low quality and small studies with various methodologies. The author suggests that a better framework would place RCTs at the top of the pyramid and relegates SRMAs to the role of a lens. The author also points out that good observational studies may be better than bad RCTs, and that each paper should be read and judged on its individual merits, not by its strata on a pyramid.
(By ChatGPT, reviewed and edited)
Source: The “evidence pyramid” should be dismantled, brick by ill-conceived brick – Sensible Medicine
Perspective | Generating scholarly content with ChatGPT: ethical challenges for medical publishing
14 Feb, 2023 | 10:58h | UTCSummary: The article discusses the ethical challenges posed by the use of ChatGPT, an AI chatbot, in medical publishing. The authors note that the impact of generative AI on medical publishing is currently unknown, but it could have substantial ethical implications, including copyright, attribution, plagiarism, and authorship issues. The authors argue that there is a growing need for robust AI author guidelines in scholarly publishing, and that the International Association of Scientific, Technical, and Medical Publishers has produced a white paper on AI ethics. They also raise concerns about the potential for ChatGPT to widen existing disparities in knowledge dissemination and scholarly publishing, as well as the potential for the chatbot to produce misleading or inaccurate content. The authors call on The Lancet Digital Health and the Lancet family to initiate discussions around the implications of AI-generated content within scholarly publishing and to create comprehensive guidance.
(By ChatGPT, reviewed and edited)
Podcast | “Things we do for no reason” pearls
14 Feb, 2023 | 10:56h | UTC#381 LIVE! Patient Centered Things We Do For No Reason – The Curbsiders
Cohort Study | In utero exposure to ADHD medication does not seem to result in worse offspring neurodevelopmental outcomes
14 Feb, 2023 | 10:54h | UTCSummary: The authors conducted a study to investigate the long-term effects of in utero exposure to ADHD medication (methylphenidate, amphetamine, dexamphetamine, lisdexamphetamine, modafinil, atomoxetine, clonidine) on offspring. The study followed 1,068,073 liveborn singletons from 1998 to 2018 and compared the outcomes of children whose mothers continued or discontinued ADHD medication during pregnancy. The main outcomes were neurodevelopmental psychiatric disorders, impairments in vision or hearing, epilepsy, seizures, or growth impairment during childhood or adolescence. After adjustment for demographic and psychiatric characteristics of the mother, no increased risk of any developmental disorders was found in offspring exposed to ADHD medication compared to those not exposed. The results provide reassurance for women with ADHD who depend on medication and consider continuing it during pregnancy.
(By ChatGPT, reviewed and edited)
Article: In utero exposure to ADHD medication and long-term offspring outcomes – Molecular Psychiatry (link to abstract – $ for full-text)
Commentary from the author on Twitter (thread – click for more)
In-utero exposure to ADHD medication is not associated with long-term adverse neurodevelopmental disorders and growth restriction in the offspring.
Read the thread below 🧵on our new paper just published in @molpsychiatry
👉 https://t.co/MKZ0aeFnhU#ADHD— Kathrine Bang Madsen (@Kathrine_BaMa) February 9, 2023
Study suggests long-term caloric restriction could slow biological aging in healthy adults
14 Feb, 2023 | 10:52h | UTCSummary: The article reports the results of a study that analyzed the impact of caloric restriction (CR), defined as reducing caloric intake without depriving essential nutrients, on DNA methylation, a measure of aging, in blood samples from the Comprehensive Assessment of Long-term Effects of Reducing Intake of Energy (CALERIE) trial. The results showed that the CALERIE intervention slowed the pace of aging, as measured by the DunedinPACE DNAm algorithm, but did not lead to significant changes in biological age estimates measured by various DNAm clocks. The authors note that while treatment effect sizes were small, a modest slowing of the pace of aging can have a significant impact on population health. They also highlight the need for further trials with long-term follow-up to establish the effects of interventions on primary healthy-aging endpoints, including the incidence of chronic disease and mortality.
(By ChatGPT, reviewed and edited)
Commentaries:
Restrict calories to live longer, study says, but critics say more proof is needed – CNN
Recommended adult immunization schedule, United States, 2023
13 Feb, 2023 | 13:06h | UTCRecommended Adult Immunization Schedule, United States, 2023 – Annals of Internal Medicine
Commentary: Recommended 2023 Adult Immunization Schedule Published – HealthDay
Commentary on Twitter
The 2023 #ACIP schedule is out now with important changes to #COVID19 and pneumococcal vaccines, including recommendations for adults who have previously received PCV13 and PPSV23: https://t.co/QeErLZJFuZ pic.twitter.com/BR6aa1kNKi
— Annals of Int Med (@AnnalsofIM) February 10, 2023
RCT | Azithromycin reduces the risk of maternal sepsis or death in women planning a vaginal birth
13 Feb, 2023 | 13:02h | UTCAzithromycin to Prevent Sepsis or Death in Women Planning a Vaginal Birth – New England Journal of Medicine (link to abstract – $ for full-text)
News Release: Single-dose antibiotic prevents maternal sepsis and death – NIH News
Commentaries:
In large study, a single antibiotic dose slashed rate of sepsis in childbirth – STAT
Dose of azithromycin found to cut risk of maternal death, sepsis in childbirth – CIDRAP
RCT | Tenecteplase noninferior to alteplase in acute ischemic cerebrovascular events
13 Feb, 2023 | 12:59h | UTCTenecteplase versus alteplase in acute ischaemic cerebrovascular events (TRACE-2): a phase 3, multicentre, open-label, randomised controlled, non-inferiority trial – The Lancet (link to abstract – $ for full-text)
Updated child and adolescent immunization schedule, United States, 2023
13 Feb, 2023 | 13:05h | UTCChild and Adolescent Immunization Schedule by Age – Centers for Diseases Control and Prevention
See also: Recommended Childhood and Adolescent Immunization Schedule: United States, 2023 – Pediatrics
Commentary: Immunization Schedule for Children, Teens Updated for 2023 – HealthDay
RCTs | Endovascular therapy improves functional outcomes in large ischemic strokes, but increases bleeding and vascular complications
13 Feb, 2023 | 13:00h | UTCStudy 1: Trial of Endovascular Thrombectomy for Large Ischemic Strokes – New England Journal of Medicine (link to abstract – $ for full-text)
Study 2: Trial of Endovascular Therapy for Acute Ischemic Stroke with Large Infarct – New England Journal of Medicine (link to abstract – $ for full-text)
M-A | Tenecteplase vs. alteplase for treatment of acute ischemic stroke
13 Feb, 2023 | 12:57h | UTCRelated: Tenecteplase versus alteplase in acute ischaemic cerebrovascular events (TRACE-2): a phase 3, multicentre, open-label, randomised controlled, non-inferiority trial – The Lancet (link to abstract – $ for full-text)
Perspective | Five new realities in critical care for patients with cancer
13 Feb, 2023 | 12:53h | UTCFive new realities in critical care for patients with cancer – Intensive Care Medicine
Related:
Consensus Conference: Critically ill cancer patient’s resuscitation.
Raising awareness for time-limited trial discussion upon ICU triage and admission.
Commentary on Twitter
New realities in critical care for pts with cancer
1️⃣ serious illness no longer means end of life
2️⃣ novel cancer therapies: changing outcomes but creating new diseases
3️⃣ take fresh look at ARF
4️⃣ goals of care & time‑limited trial
5️⃣ look beyond #ICU
📖 https://t.co/ZRNQD6AMIw pic.twitter.com/5QoYVSq5Br— Intensive Care Medicine (@yourICM) February 10, 2023
Video | ChatGPT: will it transform the world of health care?
13 Feb, 2023 | 12:55h | UTCChatGPT: Will It Transform the World of Health Care? – UCSF Department of Medicine
Related:
ChatGPT and the future of medical writing (ChatGPT itself wrote this paper)
ChatGPT: five priorities for research – Nature
The path forward for ChatGPT in academia – Lumo’s Newsletter
ChatGPT is fun, but not an author – Science
Tools such as ChatGPT threaten transparent science; here are our ground rules for their use – Nature
ChatGPT listed as author on research papers: many scientists disapprove – Nature
Abstracts written by ChatGPT fool scientists
RCT | A deprescribing intervention reduced medication burden among older adults in post-acute care
13 Feb, 2023 | 12:50h | UTCDeprescribing Medications Among Older Adults From End of Hospitalization Through Postacute Care: A Shed-MEDS Randomized Clinical Trial – JAMA Internal Medicine (free for a limited period)
Related:
Deprescribing proton pump inhibitors – Australian Journal of General Practice
Antihypertensive Deprescribing in Older Adults: a Practical Guide – Current Hypertension Reports
Deprescribing in Palliative Cancer Care – Life
Less is More: Deprescribing Medications in Older Adults with Kidney Disease: A Review – Kidney360
Polypharmacy Management in Older Patients – Mayo Clinic Proceedings
Eliminating Medication Overload: A National Action Plan – Lown Institute
Common ED Medication Errors: Polypharmacy – emDocs
Current and future perspectives on the management of polypharmacy – BMC Family Practice
Polypharmacy—an Upward Trend with Unpredictable Effects – Deutsches Ärzteblatt international
Clinical Consequences of Polypharmacy in Elderly – Expert Opinion on Drug Safety
Commentary on Twitter
A randomized trial of patient-centered #deprescribing in the acute care setting reduced medication burden by 14% among older hospitalized patients that needed ongoing post-acute care. https://t.co/FJf53O00Cv #ShedMEDS #polypharmacy #LessIsMore #Geriatrics
— JAMA Internal Medicine (@JAMAInternalMed) February 9, 2023
The Lancet Series | Breastfeeding 2023
13 Feb, 2023 | 12:52h | UTCHomepage: Breastfeeding 2023 – The Lancet
Editorial: Unveiling the predatory tactics of the formula milk industry
Breastfeeding: crucially important, but increasingly challenged in a market-driven world
Marketing of commercial milk formula: a system to capture parents, communities, science, and policy
Commentaries:
Expert reaction to review of formula baby milk – Science Media Centre
Consensus Statement | Development of an Enhanced Recovery After Surgery (ERAS) surgical safety checklist
10 Feb, 2023 | 14:03h | UTC
Commentary from the author on Twitter (thread – click for more)
The @WHO Surgical Safety Checklist and the @ErasSociety guidelines come together.🔥
#ERAS teams can leverage 2 tools in 1 to improve care in critical perioperative communication moments https://t.co/EaXYyj7b56
via @JAMANetworkOpen part of @JAMANetwork pic.twitter.com/WHJMjThubO— Mary Brindle (@MaryEBrindle) February 8, 2023
Guideline for management of septic arthritis in native joints
10 Feb, 2023 | 14:00h | UTC


